Testosterone replacement therapy and cardiovascular events
dc.authorid | Muammer Kendirci / 0000-0002-1854-1871 | en_US |
dc.authorid | Alp Burak Çatakoğlu / 0000-0002-1095-3513 | |
dc.authorscopusid | Muammer Kendirci / 8625690500 | |
dc.authorscopusid | Alp Burak Çatakoğlu / 8302304200 | |
dc.authorwosid | Muammer Kendirci / AAA-3790-2019 | |
dc.authorwosid | Alp Burak Çatakoğlu / I-1920-2015 | |
dc.contributor.author | Çatakoğlu, Alp Burak | |
dc.contributor.author | Kendirci, Muammer | |
dc.date.accessioned | 2020-08-30T20:08:01Z | |
dc.date.available | 2020-08-30T20:08:01Z | |
dc.date.issued | 2017 | |
dc.department | İstinye Üniversitesi | en_US |
dc.description.abstract | A low testosterone level and hypogonadism are associated with cardiovascular disease. Aging, chronic health problems, and obesity are all associated with a low testosterone level as well as the presence and severity of cardiovascular disease. Testosterone is increasingly prescribed for patients with clinical hypogonadism and a low testosterone level. The information we have is still contradictory regarding testosterone replacement therapy (TRT) and its association with adverse cardiovascular events. Older patients and patients who are susceptible to cardiovascular diseases could be at risk with a testosterone prescription. This is a review of the literature to discuss the cardiovascular safety of TRT. | en_US |
dc.identifier.citation | Catakoglu, A. B., & Kendirci, M. (2017). Testosterone replacement therapy and cardiovascular events. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 45(7), 664–672. https://doi.org/10.5543/tkda.2017.00531 | en_US |
dc.identifier.doi | 10.5543/tkda.2017.00531 | en_US |
dc.identifier.endpage | 672 | en_US |
dc.identifier.issn | 1016-5169 | en_US |
dc.identifier.issue | 7 | en_US |
dc.identifier.pmid | 28990951 | en_US |
dc.identifier.scopus | 2-s2.0-85049111249 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 664 | en_US |
dc.identifier.trdizinid | 282902 | en_US |
dc.identifier.uri | https://doi.org/10.5543/tkda.2017.00531 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/870 | |
dc.identifier.volume | 45 | en_US |
dc.identifier.wos | WOS:000418480800016 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | TR-Dizin | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Çatakoğlu, Alp Burak | en_US |
dc.institutionauthor | Kendirci, Muammer | en_US |
dc.language.iso | en | en_US |
dc.publisher | Turkish Soc Cardiology | en_US |
dc.relation.ispartof | Turk Kardiyoloji Dernegi Arsivi-Archives of The Turkish Society of Cardiology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Cardiovascular Events | en_US |
dc.subject | Testosterone | en_US |
dc.subject | Testosterone Replacement Therapy | en_US |
dc.title | Testosterone replacement therapy and cardiovascular events | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- H106.pdf
- Boyut:
- 349.43 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text